2-azabicyclo[3.1.1] derivatives as antagonists of the orexin-1 and orexin-2 receptors
EP3676261A1
Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonists
GB201805945D0
New compounds
GB201804745D0
New compounds
GB201717530D0
New compounds
US2018085356A1
Method of treating disease characterised by protein aggregate deposition in neuronal cells
GB201714049D0
Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonists
GB201600376D0
Novel therapeutic agents
AU2015316470A1
2-[bis(4-fluorophenyl)methyl]-2,7-diazaspiro[4.5]decan-10-one derivatives and related compounds as inhibitors of the human dopamine-active-transporter (DAT) protein for the treatment of e.g. attention deficit disorder (ADD)
US2017253615A1
Spirocyclic derivatives
CA2997869A1
N-(hetero)aryl-substituted heteroyclic derivatives useful for the treatment of diseases or conditions related to the central nervous system
